0001209191-18-039681.txt : 20180627
0001209191-18-039681.hdr.sgml : 20180627
20180627170424
ACCESSION NUMBER: 0001209191-18-039681
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180625
FILED AS OF DATE: 20180627
DATE AS OF CHANGE: 20180627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schwartz Eric
CENTRAL INDEX KEY: 0001329100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 18922413
MAIL ADDRESS:
STREET 1: C/O ERESEARCHTECHNOLOGY, INC.
STREET 2: 1818 MARKET STREET, SUITE 1000
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-25
0
0001237831
GLOBUS MEDICAL INC
GMED
0001329100
Schwartz Eric
VALLEY FORGE BUSINESS CENTER
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
0
1
0
0
Senior VP and General Counsel
Class A Common Stock
2018-06-25
4
M
0
10000
24.98
A
10000
D
Class A Common Stock
2018-06-25
4
S
0
8444
53.638
D
1556
D
Class A Common Stock
2018-06-25
4
S
0
1556
54.594
D
0
D
Stock Option (Right to Buy Class A Common Stock)
24.98
2018-06-25
4
M
0
10000
0.00
D
2026-04-28
Class A Common Stock
10000
41000
D
This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.24 to $54.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.29 to $54.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
These options were included in a grant of 75,000 options that was granted on May 3, 2016, and which vests over a four-year period with one-fourth (1/4) of the options granted vesting on April 28, 2017, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Eric I. Schwartz
2018-06-27